Stephen S. Dominy - Chief Scientific Officer, Director at Quince Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer, Director
Stock Symbol
QNCX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Stephen S. Dominy since 7/7/2023

Holdings reported by Stephen S. Dominy for Quince Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 1,217,086 $1.14 M $0.94 Nov 12, 2021 By the Dominy Family Trust 2016
Common Stock 220,588 $207 K $0.94 Nov 12, 2021 By The Stephen Dominy 2019 Annuity Trust
Stock Option (right to buy) 125,000 Jan 3, 2022 Direct Common Stock

Transactions reported by Stephen S. Dominy for Quince Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership